Ajanta Pharma informs about analyst meet

02 Feb 2026 Evaluate

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Ajanta Pharma has informed that it enclosed the schedule of Analyst/Institutional Investor Meeting with the Company. The company has confirmed that the discussion during these meetings will be strictly on the basis of already published information.

The above information is a part of company’s filings submitted to BSE.

Ajanta Pharma Share Price

2879.25 92.10 (3.30%)
03-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1702.80
Dr. Reddys Lab 1235.00
Cipla 1322.45
Zydus Lifesciences 902.95
Lupin 2186.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×